Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB) Share Price

Price 809.00p on 06-02-2026 at 19:40:08
Change -3.00p -0.37%
Buy 808.00p
Sell 805.00p
Last Trade: Buy 112.00 at 809.00p
Day's Volume: 158,941
Last Close: 809.00p
Open: 800.00p
ISIN: GB00BDFBVT43
Day's Range 795.00p - 814.00p
52wk Range: 232.50p - 950.00p
Market Capitalisation: £977.69m
VWAP: 805.16209p
Shares in Issue: 120.85m

Oxford Biomedica (OXB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 112 809.00p SI Trade
16:35:17 - 06-Feb-26
Buy* 193 809.00p SI Trade
16:35:17 - 06-Feb-26
Buy* 9 809.00p SI Trade
16:35:17 - 06-Feb-26
Buy* 4 809.00p SI Trade
16:35:17 - 06-Feb-26
Buy* 22 809.00p SI Trade
16:35:17 - 06-Feb-26
Buy* 18 809.00p SI Trade
16:35:17 - 06-Feb-26
Sell* 27,632 809.00p Uncrossing Trade
16:35:17 - 06-Feb-26
Buy* 141 807.00p Automatic Execution
16:29:55 - 06-Feb-26
Buy* 100 807.00p Automatic Execution
16:29:55 - 06-Feb-26
Sell* 112 805.00p Automatic Execution
16:28:23 - 06-Feb-26
See more Oxford Biomedica trades

Oxford Biomedica (OXB) Share Price History

Time period:
to
Date Open High Low Close Volume
6th Feb 2026 (Fri) 800.00 814.00 795.00 809.00 158,941
5th Feb 2026 (Thu) 818.00 826.00 810.00 812.00 154,372
4th Feb 2026 (Wed) 824.00 862.00 817.00 826.00 629,787
3rd Feb 2026 (Tue) 833.00 847.00 813.00 818.00 300,162
2nd Feb 2026 (Mon) 825.00 832.00 809.00 830.00 303,247
30th Jan 2026 (Fri) 845.00 850.00 831.00 831.00 345,561
29th Jan 2026 (Thu) 855.00 862.00 844.00 850.00 228,215
28th Jan 2026 (Wed) 862.00 888.00 855.00 855.00 356,464
27th Jan 2026 (Tue) 872.00 880.00 858.00 869.00 404,918
26th Jan 2026 (Mon) 870.00 879.00 860.00 864.00 114,450
23rd Jan 2026 (Fri) 884.00 884.00 852.00 871.00 192,282
22nd Jan 2026 (Thu) 900.00 900.00 850.00 853.00 362,921
21st Jan 2026 (Wed) 890.00 895.00 857.00 875.00 196,862
20th Jan 2026 (Tue) 850.00 893.00 850.00 887.00 290,275
19th Jan 2026 (Mon) 899.00 899.00 859.00 880.00 570,528
16th Jan 2026 (Fri) 917.00 950.00 899.00 899.00 384,358
15th Jan 2026 (Thu) 851.00 944.00 850.00 913.00 1,898,015
14th Jan 2026 (Wed) 743.00 805.00 729.00 804.00 449,133
13th Jan 2026 (Tue) 749.00 750.00 729.00 739.00 162,188
12th Jan 2026 (Mon) 729.00 749.00 714.00 749.00 365,142
9th Jan 2026 (Fri) 750.00 750.00 730.00 730.00 263,974
8th Jan 2026 (Thu) 721.00 765.00 717.00 751.00 710,116
7th Jan 2026 (Wed) 700.00 736.00 698.00 728.00 304,768
See more Oxford Biomedica price history

Oxford Biomedica (OXB) Regulatory News

Date Source Headline
6th Feb 2026 3:20 pm RNS Form 8.3 - Oxford Biomedica plc
6th Feb 2026 9:52 am RNS Form 8.5 (EPT/RI) - Oxford Biomedica plc
6th Feb 2026 7:00 am RNS Rule 2.9 Announcement
5th Feb 2026 3:20 pm RNS Form 8.3 - Oxford Biomedica plc
5th Feb 2026 2:34 pm RNS Form 8.5 (EPT/RI) - Replacement of Oxford Biomedi
5th Feb 2026 2:21 pm RNS Form 8.3 Oxford Biomedica plc
5th Feb 2026 1:52 pm RNS Form 8.3 Oxford Biomedica plc
5th Feb 2026 10:46 am RNS Form 8.5 (EPT/RI) - Oxford Biomedica plc
5th Feb 2026 10:41 am RNS Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc
5th Feb 2026 7:00 am RNS Rule 2.9 Announcement
See more Oxford Biomedica regulatory news

Oxford Biomedica (OXB) Share News

Oxford BioMedica expands cancer therapy deal with Bristol-Myers Squibb

4th Feb 2026 11:57

(Alliance News) - Oxford BioMedica PLC on Wednesday said it has signed a new commercial supply deal with Bristol-Myers Squibb Co. Read More

IN BRIEF: Oxford Biomedica confirms fresh EQT takeover approach

14th Jan 2026 18:53

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy developer - Says it notes recent press speculation and that it has received an unsolicited approach, regarding a possible cash takeover offer, from EQT X EUR SCSp and EQT X USD SCSp, funds managed by EQT Fund Management Sarl. Says it and EQT are in preliminary discussions to explore whether EQT could make a proposal which OXB's board would want to recommend. Previous unsolicited proposals from EQT have been rejected, as OXB's board believed they undervalued it and its prospects. Company "strongly" advises shareholders to take no action at this time. Read More

LONDON BROKER RATINGS: Berenberg raises M&S; BofA cuts Barratt Redrow

9th Jan 2026 10:04

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON BROKER RATINGS: RBC raises Diageo; BofA cuts JD Sports Fashion

6th Jan 2026 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BROKER RATINGS: JPMorgan cuts M&G, UBS cuts Trainline

8th Dec 2025 09:39

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and on Friday: Read More

See more Oxford Biomedica news
FTSE 100 Latest
Value10,369.75
Change60.53

Login to your account

Forgot Password?

Not Registered